• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Synthetic lethal interaction of CDK inhibition and autophagy inhibition in human solid cancer cell lines

Research Project

Project/Area Number 24501349
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Clinical oncology
Research InstitutionJuntendo University (2013-2014)
Tohoku University (2012)

Principal Investigator

SHUNSUKE Kato  順天堂大学, 医学(系)研究科(研究院), 教授 (40312657)

Co-Investigator(Kenkyū-buntansha) KAKUDO Yuichi  東北大学, 加齢医学研究所, 助教 (10396484)
Project Period (FY) 2012-04-01 – 2015-03-31
Project Status Completed (Fiscal Year 2014)
Budget Amount *help
¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2014: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2013: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2012: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Keywordsオートファジー / CDK阻害剤 / 分子標的治療 / 大腸がん / 血管新生阻害 / 細胞周期停止 / 化学療法 / がん
Outline of Final Research Achievements

We revealed that CDK inhibitor induced autophagy in some, but not all, solid cancer cell lines. In the cell lines showing autophagy, which was induced by CDK inhibitor, the combination of CDK inhibitor and autophagy inhibition induced apoptosis. However, it did not induce apoptosis in the cell lines in which autophagy was not induced by CDK inhibitor. These findings indicate that the autophagy induced by CDK inhibitor mimics stress-induced autophagy in some solid cancer cell lines. The combination of a small-molecule CDK inhibitor involved in G1/S arrest and an autophagy inhibitor leads to a synthetic lethal interaction and could become a new antitumor strategy for solid tumors showing cytoprotective autophagy induced by small-molecule CDK inhibitors.

Report

(4 results)
  • 2014 Annual Research Report   Final Research Report ( PDF )
  • 2013 Research-status Report
  • 2012 Research-status Report
  • Research Products

    (17 results)

All 2014 2013 2012

All Journal Article (9 results) (of which Peer Reviewed: 5 results) Presentation (8 results) (of which Invited: 3 results)

  • [Journal Article] High throughput RNAi screening identifies ID1 as a synthetic sick/lethal gene interacting with the common TP53 mutation R175H.2014

    • Author(s)
      Imai H, Kato S, Sakamoto Y, Kakudo Y, Shimodaira H, Ishioka C.
    • Journal Title

      Oncol Rep.

      Volume: 31 Issue: 3 Pages: 1043-1050

    • DOI

      10.3892/or.2013.2953

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Journal Article] 抗VEGF経路抗体薬‐ベバシズマブ,アフリベルセプト,ラムシルマブ-2014

    • Author(s)
      加藤俊介、塩野雅俊
    • Journal Title

      最新医学

      Volume: 69 Pages: 400-406

    • Related Report
      2013 Research-status Report
  • [Journal Article] Clinical usefulness of KRAS, BRAF, and PIK3CA mutations as predictive markers of cetuximab efficacy in irinotecan- and oxaliplatin-refractory Japanese patients with metastatic colorectal cancer.2013

    • Author(s)
      Soeda H, Shimodaira H, Watanabe M, Suzuki T, Gamoh M, Mori T, Komine K, Iwama N, Kato S, Ishioka C.
    • Journal Title

      Int J Clin Oncol.

      Volume: 18 Issue: 4 Pages: 670-677

    • DOI

      10.1007/s10147-012-0422-8

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Journal Article] 分子標的治療薬(抗体薬)2013

    • Author(s)
      加藤俊介
    • Journal Title

      Modern Physician

      Volume: 33 Pages: 361-363

    • Related Report
      2013 Research-status Report
  • [Journal Article] 消化器がんにおける血管新生阻害剤の役割2013

    • Author(s)
      加藤俊介
    • Journal Title

      がん分子標的治療

      Volume: 11 Pages: 119-126

    • Related Report
      2013 Research-status Report
  • [Journal Article] Kawai, S., Kato, S., Imai, H., Okada, Y., Ishioka C. Suppression of FUT1 attenuates cell proliferation in HER2-overexpressing cancer cell line NCI-N87.2013

    • Author(s)
      Kawai S, Kato S, Imai H, Okada Y, Ishioka C.
    • Journal Title

      Oncol Rep.

      Volume: 29 Issue: 1 Pages: 13-20

    • DOI

      10.3892/or.2012.2120

    • Related Report
      2012 Research-status Report
    • Peer Reviewed
  • [Journal Article] 大腸がんに対する新しい分子標的薬(レゴラフェニブとアフリバセプト)2013

    • Author(s)
      加藤俊介
    • Journal Title

      癌と化学療法

      Volume: 40 Pages: 6-9

    • Related Report
      2012 Research-status Report
  • [Journal Article] Multicenter Retrospective Study of 132 Patients with Unresectable Small Bowel Adenocarcinoma Treated with Chemotherapy2012

    • Author(s)
      Tsushima, T., Taguri, M., Honma, Y., Takahashi, H., Ueda, S., Nishina, T., Kawai, H., Kato, S., Morita, S., Boku, N
    • Journal Title

      Oncologist

      Volume: 17 Pages: 1163-1170

    • Related Report
      2012 Research-status Report
    • Peer Reviewed
  • [Journal Article] Safety Verification Trials of mFOLFIRI and Sequential IRIS + Bevacizumab as First- or Metastantic Colorectal Cancer in Japanese Patients2012

    • Author(s)
      Kato S, Andoh H, Gamoh M, Yamaguchi T, Murakawa T, Shimodaira H, Takahashi S, Mori T, Ohori H, Maeda S, Suzuki T, Kato S, Akiyama S, Sasaki Y, Yoshioka T, Ishioka C
    • Journal Title

      Oncology

      Volume: 83 Issue: 2 Pages: 101-107

    • DOI

      10.1159/000339541

    • Related Report
      2012 Research-status Report
    • Peer Reviewed
  • [Presentation] 切除不能進行再発胃がんの治療戦略2014

    • Author(s)
      加藤俊介
    • Organizer
      第12回日本臨床腫瘍学会
    • Place of Presentation
      福岡国際会議場(福岡)
    • Year and Date
      2014-07-17
    • Related Report
      2014 Annual Research Report
    • Invited
  • [Presentation] 希少がんに対する分子標的薬(軟部肉腫、GIST、NET)2014

    • Author(s)
      加藤俊介
    • Organizer
      第18回日本がん分子標的治療学会学術集会
    • Place of Presentation
      仙台市情報・産業プラザ(仙台)
    • Year and Date
      2014-06-26
    • Related Report
      2014 Annual Research Report
    • Invited
  • [Presentation] オキザリプラチン(L-OHP)起因性蓄積性末梢知覚神経障害に対する休薬期間による改善効果に関する検討2014

    • Author(s)
      加藤俊介、蒲生真紀夫、下平秀樹、村川康子、天貝賢二、伊東重豪、添田 大司、二井谷友公、吉岡 孝志、石岡 千加史
    • Organizer
      第111回日本内科学会
    • Place of Presentation
      東京国際フォーラム(東京)
    • Year and Date
      2014-04-11
    • Related Report
      2014 Annual Research Report
  • [Presentation] Synthetic lethal interaction of CDK inhibition and autophagy inhibition in human solid cancer cell lines.2013

    • Author(s)
      Okada Y, Kato S, Sakamoto Y, Oishi T, Ishioka C.
    • Organizer
      American Association for Cancer Research
    • Place of Presentation
      Washington, USA
    • Related Report
      2013 Research-status Report
  • [Presentation] 膵癌に対する分子標的薬―最近の動向2013

    • Author(s)
      加藤俊介
    • Organizer
      第21回日本消化器関連学会週間
    • Place of Presentation
      東京グランドプリンスホテル高輪
    • Related Report
      2013 Research-status Report
    • Invited
  • [Presentation] 胞巣状肉腫に対してPazopanibが奏功した2例2013

    • Author(s)
      伊藤祝栄、加藤俊介、保坂正美、綿貫宗則、鈴木賢太郎、林耕宇、秋山聖子、高橋信、高橋雅信、添田大司、井上正広、城田英和、森隆弘、下平秀樹、石岡千加史
    • Organizer
      第51回日本癌治療学会学術集会
    • Place of Presentation
      京都
    • Related Report
      2013 Research-status Report
  • [Presentation] Synthetic lethal interaction of CDK inhibition and autophagy inhibition in human solid cancer cell lines2013

    • Author(s)
      Okada Y, Kato S, Sakamoto Y, Oishi T, Ishioka C.
    • Organizer
      AACR annual meeting 2013
    • Place of Presentation
      Washington, USA
    • Related Report
      2012 Research-status Report
  • [Presentation] CDK4阻害剤とオートファジー阻害の併用はアポトーシスを誘導する2012

    • Author(s)
      岡田佳也,加藤俊介,大石隆之,坂本康寛,石岡千加史
    • Organizer
      第71回日本癌学会学術総会
    • Place of Presentation
      札幌
    • Related Report
      2012 Research-status Report

URL: 

Published: 2013-05-31   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi